Tag: dong-a st

dong-a st

Latest News

Dong-A ST anchors ESG in ‘warm’ growth strategy

Dong-A ST is internalizing its environmental, social and governance (ESG) management strategy to push for a leading role in the global pharmaceutical industry.

2026.6.30

A researcher at an AbTis laboratory. [DONG-A ST]

Korean firms lead the charge in the ADC market

A new trend is sweeping the global oncology market: antibody-drug conjugates (ADCs). Pharmaceutical companies developing ADCs are gaining traction, raising interest in the compounds that will follow.

2024.10.31

Most popular

Dong-A ST headquarters in Seoul [DONG-A ST]

R&D focus sets Dong-A ST apart in biosimilars

Dong-A ST’s consistent focus on research and development (R&D), ranging from biosimilars to anti-obesity drugs, has enabled the pharmaceutical company to make significant strides with new offerings such as the Stelara biosimilar DMB-3115.

2024.6.28

Dong-A ST and Meiji Seika sign ustekinumab deal with Intas

Dong-A ST and Tokyo’s Meiji Seika Pharma have signed a deal with Ahmedabad, India’s Intas Pharmaceuticals to license DMB-3115, biosimilar referencing psoriasis treatment Stelara, the Korean company announced Wednesday.

2021.7.21

Tag: dong-a st

dong-a st

Latest News

Dong-A ST anchors ESG in ‘warm’ growth strategy

Korean firms lead the charge in the ADC market

Most popular

Veteran actors Yoo Hae-jin, Ryu Seung-ryong win Baeksang Grand Prizes — as it happened

BTS comeback: Bright lights and drone shows light up the sky as 'Arirang' finally arrives — as it happened

179 dead after Jeju Air flight 7C2216 crashes at Muan International Airport — as it happened

Rooney, Maicon, Park Joo-ho score as Shield United wins Icons Match in Seoul — as it happened

Kim Soo-hyun addresses Kim Sae-ron relationship — as it happened

R&D focus sets Dong-A ST apart in biosimilars

Dong-A ST and Meiji Seika sign ustekinumab deal with Intas